S&P 500   4,617.98 (+0.30%)
DOW   36,350.98 (+0.28%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,617.98 (+0.30%)
DOW   36,350.98 (+0.28%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,617.98 (+0.30%)
DOW   36,350.98 (+0.28%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)
S&P 500   4,617.98 (+0.30%)
DOW   36,350.98 (+0.28%)
QQQ   395.49 (+0.85%)
AAPL   192.88 (-1.45%)
MSFT   369.96 (-1.14%)
META   325.67 (-2.13%)
GOOGL   132.69 (-1.70%)
AMZN   145.77 (-1.12%)
TSLA   240.31 (-1.45%)
NVDA   468.83 (-1.31%)
NIO   7.69 (+4.20%)
BABA   71.41 (-1.01%)
AMD   134.39 (+4.24%)
T   16.68 (-1.42%)
F   11.12 (+1.00%)
MU   78.33 (+4.50%)
CGC   0.76 (-5.46%)
GE   120.25 (-0.28%)
DIS   92.11 (-0.76%)
AMC   7.03 (+1.44%)
PFE   28.53 (-0.87%)
PYPL   59.23 (+0.49%)
XOM   99.50 (-0.05%)

Cepton (CPTN) Stock Price, News & Analysis

$4.02
-0.48 (-10.67%)
(As of 02:34 PM ET)
Compare
Today's Range
$4.02
$4.50
50-Day Range
$2.70
$4.80
52-Week Range
$2.38
$14.40
Volume
12,190 shs
Average Volume
50,971 shs
Market Capitalization
$63.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPTN stock logo

About Cepton Stock (NASDAQ:CPTN)

Cepton, Inc. provides lidar-based solutions for automotive, smart cities, smart spaces, and smart industrial applications in the United States, Japan, China, and internationally. The company offers autograde lidar sensors, including Vista-X, a compact lidar solution with a range of up to 200m for long-range applications in ADAS L2+/L3, AV L4/L5, and suitable for smart infrastructure applications; and Nova, an ultra-small form factor lidar solution with a range of up to 30m for near-range applications in ADAS L2+/L3, AV L4/L5, and suitable for smart infrastructure applications. It also provides industrial grade lidar sensors, such as Vista-P, a compact lidar solution with a range of up to 200m for long-range applications in ADAS L2+/L3, AV L4/L5, and smart infrastructure applications; and Sora-P, an ultra-high scan rate, compact, and quasi line-scanning lidar solution that delivers high-fidelity profiling of objects moving at high speeds for free flow tolling and other industrial applications. The company was founded in 2016 and is headquartered in San Jose, California.

CPTN Stock Price History

CPTN Stock News Headlines

Cepton reports surge in 3Q revenue on record shipments
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Cepton, Inc. Reports Third Quarter 2023 Results
Cepton Inc CPTN
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Cepton says 1-for-10 reverse stock split now effective
Cepton’s 1-for-10 Reverse Stock Split Becomes Effective
Cepton Appoints Mitch Hourtienne to Chief Commercial Officer
Cepton (NASDAQ: CPTN) CFO Featured in Proactive Interview
Cepton is pioneering Lidar solutions for automotive and beyond
Cepton (CPTN) Receives a Hold from RBC Capital
See More Headlines
Receive CPTN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cepton and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/11/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/12/2024

Industry, Sector and Symbol

Industry
Motor vehicle parts & accessories
Sub-Industry
N/A
Current Symbol
NASDAQ:CPTN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$9.38 million
Net Margins
-573.05%
Pretax Margin
-573.06%

Debt

Sales & Book Value

Annual Sales
$9.68 million
Book Value
$0.10 per share

Miscellaneous

Free Float
9,793,000
Market Cap
$63.70 million
Optionable
Not Optionable
Beta
0.02
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Jun Pei (Age 54)
    Co-Founder, President, CEO & Chairman of the Board
    Comp: $312.38k
  • Mr. Hull Xu (Age 49)
    Chief Financial Officer
    Comp: $296.14k
  • Dr. Liqun Han (Age 54)
    Chief Operating Officer
    Comp: $272.38k
  • Dr. Mark McCord (Age 61)
    Co-Founder & Chairman of Technology Advisory Board
    Comp: $224.34k
  • Dr. Dongyi Liao (Age 46)
    Chief Technology Officer
    Comp: $224.34k
  • Mr. Mitch Hourtienne
    Chief Commercial Officer
  • Mr. Brunno Moretti
    Senior Vice President of Product & Commercial Operations
  • Ms. Jinying Chen (Age 49)
    Corporate Controller














CPTN Stock Analysis - Frequently Asked Questions

Should I buy or sell Cepton stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cepton in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" CPTN shares.
View CPTN analyst ratings
or view top-rated stocks.

How have CPTN shares performed in 2023?

Cepton's stock was trading at $12.70 on January 1st, 2023. Since then, CPTN stock has decreased by 68.3% and is now trading at $4.02.
View the best growth stocks for 2023 here
.

Are investors shorting Cepton?

Cepton saw a decline in short interest in November. As of November 15th, there was short interest totaling 88,800 shares, a decline of 11.3% from the October 31st total of 100,100 shares. Based on an average daily trading volume, of 33,800 shares, the days-to-cover ratio is presently 2.6 days. Approximately 1.9% of the company's shares are short sold.
View Cepton's Short Interest
.

When is Cepton's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 12th 2024.
View our CPTN earnings forecast
.

How were Cepton's earnings last quarter?

Cepton, Inc. (NASDAQ:CPTN) issued its earnings results on Thursday, November, 9th. The company reported ($0.58) EPS for the quarter, topping analysts' consensus estimates of ($0.70) by $0.12. The firm had revenue of $3.83 million for the quarter, compared to analysts' expectations of $5.10 million. Cepton had a negative net margin of 573.05% and a negative trailing twelve-month return on equity of 783.92%.

When did Cepton's stock split?

Shares of Cepton reverse split before market open on Friday, September 22nd 2023. The 1-10 reverse split was announced on Monday, September 18th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has Cepton issued on next quarter's earnings?

Cepton issued an update on its FY 2023 earnings guidance on Monday, December, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $9.0 million-$11.0 million, compared to the consensus revenue estimate of $17.1 million.

Who are Cepton's major shareholders?

Cepton's stock is owned by many different institutional and retail investors. Top institutional shareholders include Trellus Management Company LLC (0.37%), Empower Advisory Group LLC (0.09%) and Jacobs Levy Equity Management Inc. (0.09%). Insiders that own company stock include Jun Pei, Liqun Han, Mark Mccord and Ming Qiu.
View institutional ownership trends
.

How do I buy shares of Cepton?

Shares of CPTN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CPTN) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -